# Junta clínica — PT-pseudo_5af00f9153c2 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_5af00f9153c2",
  "pid": "PT-pseudo_5af00f9153c2",
  "task": 1,
  "psa": 11.2,
  "age": 64,
  "months": 2,
  "pirads": "5",
  "psad": 0.18,
  "psav": 1.9,
  "psap": 7.5,
  "vol": 61.0,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.8541575,
  "medhx": "Type 2 diabetes, Hypercholesterolaemia, Chronic kidney disease",
  "meds": "metformin, empagliflozin, atorvastatin, simvastatin, rosuvastatin",
  "notes": "PSA 11.2 ng/mL. PI-RADS 5. PSAD 0.18. Prostate volume 61 mL. csPCa 0.85.",
  "pmhx": [
    "Type 2 diabetes",
    "Hypercholesterolaemia",
    "Chronic kidney disease"
  ],
  "allergies": [],
  "vitals": {
    "weight": "95 kg",
    "height": "173 cm",
    "bmi": "31.7",
    "bp": "99/73 mmHg",
    "hr": "81 bpm",
    "smoking": "Ex-smoker (29 pack-yr, quit 2001)",
    "last_dental": "6 mo ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "31 Jan 2025",
  "enc_ref": "Dr. P. van Dijk (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Evaluation initiated after documenting a sustained PSA elevation alongside a previous biopsy result establishing ISUP grade group 4 malignancy."
    },
    {
      "s": "History",
      "t": "A 64-year-old factory supervisor, currently cohabiting with his partner after a divorce, seeks re-assessment of a known prostate malignancy. His PSA values have climbed steadily from 3.3 ng/mL in early 2023 to the present 11.2 ng/mL. Underlying type 2 diabetes and chronic kidney disease are managed with metformin and empagliflozin, while hypercholesterolaemia is addressed through a combination of atorvastatin, simvastatin, and rosuvastatin. His estimated glomerular filtration rate has held steady beneath 60 mL/min/1.73m2. Urological discomfort is negligible, reflected by an IPSS score of 4, and he denies any blood in the urine or voiding difficulties. A significant smoking background of 29 pack-years ended in 2001; alcohol consumption remains limited to four units per week. He favors weekend gardening over formal exercise routines. Recent non-urological care included a standard chest radiograph and an audiology check for mild age-related hearing shifts, alongside a persistent sleep disturbance he links to occupational stress. Due to residing over ninety minutes from the clinic, he has asked that telephone consultations be utilized whenever medically suitable."
    },
    {
      "s": "Physical examination",
      "t": "Digital rectal assessment: Normal DRE — prostate measures approximately 60 g with a smooth, firm consistency and no detectable nodules or asymmetry.\nSystemic evaluation shows no abnormalities. Vital parameters remain stable at a blood pressure of 99/73 mmHg and a heart rate of 81 bpm. Body mass index registers at 31.7, aligning with his reported activity levels. Peripheral lymph nodes are non-palpable, and suprapubic regions exhibit no tenderness."
    }
  ],
  "occupation": "factory supervisor",
  "marital": "Divorced",
  "living": "Lives with partner",
  "next_of_kin": "Sibling (brother)",
  "recent_other": [
    "Audiology — hearing test",
    "Radiology — chest X-ray (routine)"
  ],
  "alcohol": "4 units / week",
  "exercise": "Gardening, no structured exercise",
  "ipss": "IPSS score: 4/35 (mild LUTS)",
  "admin": "Lives >90 min from clinic; phone follow-up preferred where clinically safe.",
  "mri_hospital": "Jeroen Bosch Ziekenhuis ('s-Hertogenbosch)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_5af00f9153c2
Task: 1

Encounter: Urology - outpatient on 31 Jan 2025.
Referrer: Dr. P. van Dijk (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 64-year-old male
  - PSA: 11.2 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.18 ng/mL²
  - PSA velocity: 1.9 ng/mL/yr
  - Prior PSA: 7.5 ng/mL
  - Prostate volume: 61.0 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8541575 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Type 2 diabetes, Hypercholesterolaemia, Chronic kidney disease
  - Problem list / PMHx: Type 2 diabetes, Hypercholesterolaemia, Chronic kidney disease
  - Current medication: metformin, empagliflozin, atorvastatin, simvastatin, rosuvastatin
  - Allergies: NKA
  - Additional notes: PSA 11.2 ng/mL. PI-RADS 5. PSAD 0.18. Prostate volume 61 mL. csPCa 0.85.

Vitals: weight 95 kg, height 173 cm, BMI 31.7, BP 99/73 mmHg, HR 81 bpm. Smoking: Ex-smoker (29 pack-yr, quit 2001).

Chief complaint: Evaluation initiated after documenting a sustained PSA elevation alongside a previous biopsy result establishing ISUP grade group 4 malignancy.

History: A 64-year-old factory supervisor, currently cohabiting with his partner after a divorce, seeks re-assessment of a known prostate malignancy. His PSA values have climbed steadily from 3.3 ng/mL in early 2023 to the present 11.2 ng/mL. Underlying type 2 diabetes and chronic kidney disease are managed with metformin and empagliflozin, while hypercholesterolaemia is addressed through a combination of atorvastatin, simvastatin, and rosuvastatin. His estimated glomerular filtration rate has held steady beneath 60 mL/min/1.73m2. Urological discomfort is negligible, reflected by an IPSS score of 4, and he denies any blood in the urine or voiding difficulties. A significant smoking background of 29 pack-years ended in 2001; alcohol consumption remains limited to four units per week. He favors weekend gardening over formal exercise routines. Recent non-urological care included a standard chest radiograph and an audiology check for mild age-related hearing shifts, alongside a persistent sleep disturbance he links to occupational stress. Due to residing over ninety minutes from the clinic, he has asked that telephone consultations be utilized whenever medically suitable.

Physical examination: Digital rectal assessment: Normal DRE — prostate measures approximately 60 g with a smooth, firm consistency and no detectable nodules or asymmetry.
Systemic evaluation shows no abnormalities. Vital parameters remain stable at a blood pressure of 99/73 mmHg and a heart rate of 81 bpm. Body mass index registers at 31.7, aligning with his reported activity levels. Peripheral lymph nodes are non-palpable, and suprapubic regions exhibit no tenderness.

Patient info: factory supervisor; Divorced; Lives with partner.
Next of kin: Sibling (brother).

Lifestyle: alcohol 4 units / week; exercise Gardening, no structured exercise; IPSS score: 4/35 (mild LUTS).

Recent other appointments: Audiology — hearing test; Radiology — chest X-ray (routine).
Admin: Lives >90 min from clinic; phone follow-up preferred where clinically safe.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.58
  uncertainty  +/- 0.11 epistemic (95% band 0.36-0.80); among patients I cannot tell apart the outcome was 0.98 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 3 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 64 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 11.2 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 61 mL (1% of my signal; from log_vol, vol) · PSA density = 0.18 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.85 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 64 · DRE = Normal · PSA = 11.2 ng/mL · prostate volume = 61 mL · PSA density = 0.18 · PI-RADS = 5 · comorbidity = 3 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.74: PI-RADS 5, PSA 12.0, PSAD 0.28, age 61, DRE Normal -> DEFER (borderline). He wrote: "Young patient with elevated PSA (>10), elevated PSA density, PIRADS5 and ISUP GG2 disease -> low threshold for recommending curative treatment. IF patient does not want…"
  2. distance 1.00: PI-RADS 5, PSA 19.0, PSAD 0.37, age 65, DRE Normal -> DEFER (clear). He wrote: "Patient needs treatment without repeat biopsy as earlier biopsy showed ISUP4"
  3. distance 1.16: PI-RADS 5, PSA 11.0, PSAD 0.108, age 70, DRE Normal -> BIOPSY (borderline). He wrote: "Patient on Activ Surveillance with severe LUTS symptoms. There are two options , recommend surgery direkt or do a new biopsy."

PRECEDENT: DEFER (weighted vote 0.27 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · age = 64 · PSA = 11.2 ng/mL · PSA density = 0.18 · PI-RADS = 5
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 61 mL
  not used   csPCa probability, comorbidity
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 64 · PSA = 11.2 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 61 mL · PSA density = 0.18 · comorbidity = 3 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
"linking PI-RADS score (1-2, 3, and 4-5) to PSA-D categories (< 0.10, 0.10-0.15, 0.15-0.20ng/mL) (Table 5.5) [230]. This risk-adapted matrix table may guide the decision to perform a biopsy."
The guideline suggests using the PI-RADS score and PSA density to guide the decision to perform a biopsy. For a patient with a PI-RADS 5 and a PSA density of 0.18 ng/mL², this places him in the Intermediate-high risk category according to the guideline's risk data table.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I note that the guideline treats the PSA density level as a factor in the risk-adapted matrix. EXPERT-COHORT marks the prior biopsy as decisive, which the guideline treats as context. The guideline suggests that for a patient with a PI-RADS 5 and PSA density of 0.18 ng/mL², the decision should be guided by the risk-adapted matrix, which is a factor the guideline treats as context. The guideline requires the prior grade of the prior biopsy to be established to determine the next step, which is a fact the panel does not represent.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: at Positive the guideline suggests the next step depends on the prior grade, which is not specified in the notes; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trend: the guideline uses PSA density as a risk factor, which is a variable that the guideline makes decisive for a man in this situation.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges entirely on establishing the grade of the prior biopsy, as the cohort expert noted that the panel alone is insufficient.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Determine whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> Determine the PSA trend to assess risk factors.
  previous_notes (get_previous_notes) -> Establish the grade of the prior biopsy and surveillance status.
  laboratory_results (get_lab_results) -> Determine the DRE finding filing.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the GRADE of the prior biopsy?
  Q2. Does the radiology_report indicate whether the lesion is compared against an earlier study?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
COMPARISON: new
LESION: size and zone of the index lesion, as the report words it: "a discrete hypointense focus occupies the left peripheral zone near the base-mid transition, spanning roughly 18 x 15 x 12 mm."

psa_trend
PSA 3.8 (Mar 2023) rising to 11.2 (Jan 2025), steepest in the last year.

previous_notes
PRIOR GRADE: not recorded
BIOPSY SESSIONS: not recorded
SURVEILLANCE: not recorded
TREATMENT: none recorded

laboratory_results
DRE finding filing: "Normal"

WHAT I DID NOT OPEN
family-history anamnesis, because the cohort expert noted it was not weighed in the panel and I must adhere to the plan.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 5 and PSA density of 0.18 ng/mL² place him in the Intermediate-high risk category according to the EAU guideline.
PSA trend shows a significant rise from 3.8 ng/mL in Mar 2023 to 11.2 ng/mL in Jan 2025.

AGAINST sampling this patient now
Prior biopsy was Positive, meaning the decision hinges on the prior grade which is not established in the notes.

WHERE THIS LEANS
LEAN: unclear

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 11.20 ng/mL over 5 points spanning 22 months; velocity +3.98 ng/mL per year; doubling time about 14 months.
PROJECTION at 6 months: 15.4 ng/mL, conformal 95% band 4.4-53.7.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 11.2 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.56
  uncertainty  +/- 0.09 epistemic (95% band 0.39-0.73), of which 0.00 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 11.2 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 61 mL (4% of my signal; from log_vol, vol) · PSA density = 0.18 (0% of my signal; from psad_calc) · comorbidity = 3 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.58  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.56  ('discuss' tier, fusion_full; weight 1.5)
  EXPERT-LIBRARY     DEFER, p(biopsy)=0.27  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.57 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-LIBRARY. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          64                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          11.2 ng/mL                   E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          61 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.18                         E1:not E3:not cohort:not library:IMP E2:—            -> noted
  cspca        0.85                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  3 on the problem list        E1:IMP E3:not cohort:not library:— E2:—              -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: borderline.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes, laboratory_results) have not fully answered the moderator's questions. Specifically, the `previous_notes` state "PRIOR GRADE: not recorded," which directly answers Q1, but the other documents do not address Q2.

ALIGNMENT WITH THE PANEL
The retrieved evidence does not directly overturn the PANEL-PROTOCOL's answer of BIOPSY, as the critical missing piece—the prior biopsy grade—remains unestablished in the notes. The panel's decision rests on the trained experts' weighted vote because the documents did not record the prior grade.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the GRADE of the prior biopsy? Answered by `previous_notes`: "PRIOR GRADE: not recorded."
Q2. Does the radiology_report indicate whether the lesion is compared against an earlier study? Answered by `radiology_report`: "COMPARISON: new."

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: Positive (noted) because the panel protocol states this is decisive, and the registrar confirmed the prior biopsy was positive. I would move this to 'decisive' because the panel explicitly states it is decisive, and the lack of grade is the only barrier.
<psa>: 11.2 ng/mL (important) because the EAU guideline suggests this variable, combined with PI-RADS 5 and PSA density 0.18 ng/mL², places the patient in an Intermediate-high risk category. I agree with the panel's weighting here.
<comorbidity>: 3 on the problem list (important) because Expert-STRUCTURED weighted this as important, and the patient has significant comorbidities (T2DM, CKD).

MY SUGGESTION TO THE CHAIR
The record is ready for a decision because all documents listed by the trace model were opened. However, the decision remains contingent on the unrecorded prior biopsy grade. Given the high-risk features (PI-RADS 5, high PSA density, rising PSA trend) and the lack of prior grade, I suggest proceeding with a biopsy to establish the necessary tissue diagnosis.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: borderline)

64y/o, PSA 11.2, PSAD 0.18, PI-RADS 5, prior biopsy grade not recorded. High PI-RADS and rising PSA suggest need for tissue diagnosis. Lack of prior grade mandates biopsy to determine management pathway.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
